Cogent Biosciences Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 11.35, 345.28, 686.1, 1264.16, 1679.05 ], "ebit_estimate": [ -414.69, -168.52, 45.17, 408.41, 738.95 ], "ebitda_estimate": [ -358.31, -205.38, 118.06, 326.01, null ], "net_income_estimate": [ -396.16, -163.29, 97.2, 473.65, 802.09 ], "per_share_eps_estimate": [ -2.29, -0.89, 0.53, 2.6, 4.19 ], "eps_nri_estimate": [ -2.3, -0.83, 0.49, 2.53, 4.19 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 1.95, 1.95, 2.8, null, null ], "pretax_income_estimate": [ -396.49, -156.86, 106.97, 519.62, 909.42 ], "operating_cash_flow_per_share_estimate": [ -1.9, -0.95, 0.47, null, null ], "roa_estimate": [ -41.6, -38.8, -6.8, null, null ], "roe_estimate": [ -80.01, -54.99, 14.56, null, null ], "gross_margin_estimate": [ 90.3, 90.72, 91.2, 92.6, 93.63 ], "operating_cash_flow_estimate": [ -308.17, -153.27, 75.42, null, null ], "pettm_estimate": [ 0, 0, 72.79, 14.94, 9.27 ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": 46.06, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -2.68, "future_operating_cash_flow_per_share_estimate_growth": null }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, 2.55, 10.75, 36.85, 60.46, 90.71, 125, 123.16 ], "ebit_estimate": [ -104.29, -107.21, -103.3, -82.51, -71.42, -55.16, -37.42, null ], "ebitda_estimate": [ -96.86, -99.73, -85.84, null, null, null, null, null ], "net_income_estimate": [ -100.26, -103.13, -101.62, -77.31, -67.2, -50.6, -33.71, null ], "per_share_eps_estimate": [ -0.57, -0.58, -0.57, -0.5, -0.44, -0.34, -0.24, null ], "eps_nri_estimate": [ -0.57, -0.59, -0.58, -0.44, -0.36, -0.24, -0.11, -0.2 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -100.62, -103.51, -101.57, -77.31, -67.2, -50.6, 272.34, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, 97, 93.5, 89, 89, 89, 89, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 0, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": null, "future_eps_nri_estimate_growth": null, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": 46.06, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": -2.68, "future_operating_cash_flow_per_share_estimate_growth": null }